about
Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in miceRegulation of bile acid synthesis by the nuclear receptor Rev-erbalphaPeroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in miceKetone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Pparα DeficiencyInterspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontinLiver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.The logic of transcriptional regulator recruitment architecture at cis-regulatory modules controlling liver functions.PPARalpha regulates the production of serum Vanin-1 by liver.Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia.Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-alpha control of the acute-phase response.The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in miceEffects of Pinus pinaster and Pinus koraiensis seed oil supplementation on lipoprotein metabolism in the ratPinus pinaster oil affects lipoprotein metabolism in apolipoprotein E-deficient miceComparison of maritime pine oil and fish oil effects on plasma lipoproteins in apolipoprotein E-deficient miceEffects of dietary maritime pine (Pinus pinaster)-seed oil on high-density lipoprotein levels and in vitro cholesterol efflux in mice expressing human apolipoprotein A-I
P50
Q24294997-333D6EF4-0CB4-4FC8-A063-E017B2519945Q24316352-E24B54C4-9046-44F3-933D-21E6AF780366Q28585608-35A0D06F-BC8E-43EE-A856-4040D151B6A1Q30513404-CE126D0C-E4F6-44BF-A0C2-DE999039D53FQ33631584-8A600AF6-422E-46ED-8D9D-DD4981058194Q33877800-5D314CE9-FAA5-467C-B923-3DB719761E8DQ37398932-6ED06966-A3A4-4531-B39E-3DA96482425FQ45054466-65EA5CAC-AD37-45C6-8A1B-E85F7D0AFE96Q45775414-06DB55DE-CABE-459F-8434-2C07A2A64197Q46460426-C2D8160C-AEEA-4347-9735-71D37ABB614CQ46714334-A3DEAA24-D341-4452-B879-390551ACF907Q57244037-13CE2744-9309-4BB4-94AE-FC7492AC3B5DQ57244336-09B4E324-7520-4E4F-9704-318B8A75C3F8Q73128277-BE99473F-2E1B-4BBC-8270-074DFB1589BCQ73960726-B8FCCB87-93AB-4475-9B4C-1EE3D2A5049BQ74249810-22D10414-7724-496F-A563-E16B4874F543
P50
description
researcher ORCID ID = 0000-0001-9994-8667
@en
wetenschapper
@nl
name
Eric Baugé
@ast
Eric Baugé
@en
Eric Baugé
@nl
type
label
Eric Baugé
@ast
Eric Baugé
@en
Eric Baugé
@nl
prefLabel
Eric Baugé
@ast
Eric Baugé
@en
Eric Baugé
@nl
P106
P31
P496
0000-0001-9994-8667